Michael Palese

rdf:langString Michael Palese

rdf:langString Michael A. Palese, M.D.

rdf:langString Michael A. Palese, M.D.

rdf:langString Minimally Invasive Surgery

rdf:langString Mount Sinai School of Medicine

rdf:langString Dr. Michael A. Palese, is an American urologist specializing in robotic, laparoscopic and endoscopic surgery, with a special emphasis on robotic surgeries relating to kidney cancer and kidney stone disease. Palese is the Chairman of the Department of Urology at the Mount Sinai Beth Israel. He is a professor at the Icahn School of Medicine at Mount Sinai in New York City. He is also the Director of Minimally Invasive Surgery for the Mount Sinai Health System and specializes in robotic, laparoscopic and endoscopic surgery. As a board-certified urologist and fellowship-trained surgeon, he specializes in the diagnosis and treatment of kidney, ureter, adrenal, bladder and prostate disease. Palese performed the first robotic radical nephrectomy, robotic partial nephrectomy, robotic donor nephrectomy, robotic nephroureterectomy, robotic adrenalectomy, and robotic ureteral reimplant & reconstruction at the Mount Sinai Medical Center in New York City. He holds several patents for the design of novel surgical devices. He has been included in the Castle Connolly's List of America's “Top Doctors” in 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018 & 2019 and The New York Times publication of “Superdoctors” in 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018 & 2019.